Max Beugeling is a Principal Scientist in CAR-T Cell Drug Product Development at Galapagos, with a strong background in pharmaceutical technology and biopharmacy. They hold a Ph.D. in Pharmaceutical Technology from the University of Groningen, where they also earned a Master's and Bachelor's degree in Pharmacy. Previously, Max has contributed to formulation development at Janssen Pharmaceutical Companies of Johnson & Johnson and has supervised pharmacy students during their academic pursuits. They have expertise in stability studies, formulation development, and effective scientific communication.
This person is not in the org chart
This person is not in any teams
This person is not in any offices